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Collagen IV- and laminin-rich decellularised dermis scaffolds support a mucociliary airway epithelial
graft but in vivo transplantation in pre-clinical models is challenging http://bit.ly/2IdQp5d
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ABSTRACT Current methods to replace damaged upper airway epithelium with exogenous cells are
limited. Existing strategies use grafts that lack mucociliary function, leading to infection and the retention
of secretions and keratin debris. Strategies that regenerate airway epithelium with mucociliary function are
clearly desirable and would enable new treatments for complex airway disease.
Here, we investigated the influence of the extracellular matrix (ECM) on airway epithelial cell adherence,
proliferation and mucociliary function in the context of bioengineered mucosal grafts. In vitro, primary human
bronchial epithelial cells (HBECs) adhered most readily to collagen IV. Biological, biomimetic and synthetic
scaffolds were compared in terms of their ECM protein content and airway epithelial cell adherence.
Collagen IV and laminin were preserved on the surface of decellularised dermis and epithelial cell
attachment to decellularised dermis was greater than to the biomimetic or synthetic alternatives tested.
Blocking epithelial integrin α2 led to decreased adherence to collagen IV and to decellularised dermis
scaffolds. At air–liquid interface (ALI), bronchial epithelial cells cultured on decellularised dermis scaffolds
formed a differentiated respiratory epithelium with mucociliary function. Using in vivo chick
chorioallantoic membrane (CAM), rabbit airway and immunocompromised mouse models, we showed
short-term preservation of the cell layer following transplantation.
Our results demonstrate the feasibility of generating HBEC grafts on clinically applicable decellularised
dermis scaffolds and identify matrix proteins and integrins important for this process. The long-term
survivability of pre-differentiated epithelia and the relative merits of this approach against transplanting
basal cells should be assessed further in pre-clinical airway transplantation models.
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Introduction
The respiratory mucosa lines the internal surface of the trachea and bronchi and consists of a
pseudostratified, multiciliated epithelium containing mucus-secreting goblet cells [1]. The respiratory
mucosa performs a vital array of functions, including acting as a barrier against infection and clearing
secretions from the lower airways via the mucociliary escalator [2, 3]. Existing methods to restore
respiratory mucosa following airway reconstruction and cancer resection rely on the transfer of muscle on
a vascularised pedicle and skin grafting. Whilst these can re-epithelialise small sections of airway, they are
not suitable for reconstruction of larger areas as the epithelium retains stratified squamous histology and
thus lacks the ciliated and mucosecretory cells required for normal functionality [4]. The epidermis also
has a higher rate of epithelial turnover than respiratory epithelium, which may contribute to airway
sloughing and obstruction in these patients [5]. Buccal epithelium has been used in mucosal grafts and
successfully applied to restore small sections of tracheal mucosa [6]; however, due to limitations in the
extent of donor tissue that can be harvested, this approach is also not suitable for extensive proximal
airway repair.
The ability to regenerate a transplantable respiratory mucosal layer with mucociliary function would be a
significant step forward in the field of airway regenerative medicine. It would enable new therapies to treat
long-segment mucosal diseases of the upper airways, including complex scarring and granulomatous
conditions. Such a technique would also be highly relevant to gene editing approaches to treat genetic
disorders such as cystic fibrosis, where cell engraftment poses a major challenge [7]. Examples of
bioengineered tracheal replacements have been limited by slow mucosalisation following implantation [8–
10] and bioengineered respiratory mucosal grafts might improve the safety and efficacy of such procedures.
Current reports of in vitro bioengineered upper airway mucosa have mainly focused on regenerating the
mucosal layer on tracheal scaffolds [11, 12]. However, the in vivo application of these techniques is limited
by the time taken for revascularisation to occur following transplantation. To overcome this, we envisage
the use of a two-stage procedure [13] whereby a mucosal layer composed of respiratory cells (rather than
cells from other epithelia, e.g. buccal [14, 15]) is generated in vitro and can be used to re-epithelialise a
pre-vascularised implanted airway scaffold or be grafted directly onto the airway to replace damaged
mucosa. This methodology more closely follows the principles of free tissue transfer, where
well-vascularised graft beds are essential for successful outcomes [16].
In formulating a method to regenerate respiratory mucosa, careful consideration needs to be given to the
extracellular matrix (ECM) environment. The ECM is a complex network of macromolecular proteins that
are bound by specific cation-dependent cell surface receptors, the integrins, on the basolateral surface of
epithelial cells [17]. Integrin–ECM binding leads to cascades of intracellular signalling that influence
multiple cellular processes including attachment, proliferation, polarity and programmed cell death [18].
Evidence from investigations of the ECM in stratified epithelia, along with proteomic data examining the
composition of the upper airway basement membrane, indicate that collagen I, collagen IV, laminin,
vitronectin and fibronectin play important roles in modifying epithelial cell behaviour [19–21]. Here, the
effect of these ECM proteins on respiratory epithelial cell attachment, expansion and differentiation in vitro
was investigated with a view to optimising the ECM environment for bioengineered airway mucosa.
Materials and methods
Primary cell culture
Primary human bronchial epithelial cells (HBECs) were isolated from endobronchial biopsies from the
human adult upper airways or from the bronchi of patients undergoing lobectomy (supplementary table
S1). Ethical approval was obtained from a Research Ethics Committee (REC references: 06/Q0505 and 11/
LO/1522). HBECs were maintained in bronchial epithelial growth medium (BEGM) (Lonza, Slough, UK)
for attachment and proliferation experiments. For differentiation experiments, HBECs that had been
isolated and maintained on mitomycin C-treated 3T3-J2 feeder layers with 5 µM ROCK inhibitor Y-27632
(3T3+Y) (Enzo Life Sciences, Exeter, UK) were used as previously described [22–24]. Cells isolated and
expanded in BEGM were used between passages one to three, while cells isolated and expanded in 3T3+Y
were used between passages one to six. Primary human lung fibroblasts were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) (Gibco, Hemel Hempstead, UK) containing 10% foetal bovine serum
(FBS) and were used no later than passage ten.
Coating of tissue culture plastic with extracellular matrix protein
ECM proteins were used to coat tissue culture plastic using the recommended manufacturer’s
concentrations and a value above (high) and below (low) that concentration (medium). The ECM proteins
used were collagen I from human neo-natal fibroblasts (Advanced Biomatrix, San Diego, USA) at
38.7 µg·mL−1, 387 µg·mL−1 and 968 µg·mL−1; collagen IV from human placenta (C8374, Sigma-Aldrich,
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Dorset, UK) at 10 µg·mL−1, 250 µg·mL−1 and 500 µg·mL−1; vitronectin from human plasma (V8379,
Sigma-Aldrich) at 0.5 µg·mL−1, 1.25 µg·mL−1 and 2.5 µg·mL−1; laminin from human placenta (L6274,
Sigma-Aldrich) at 1 µg·mL−1, 2 µg·mL−1 and 4 µg·mL−1; and 0.1% fibronectin from human plasma
(F0895, Sigma-Aldrich) at 1 µg·mL−1, 25 µg·mL−1 and 250 µg·mL−1. Non-adherent 96-well plates (10554
961, Fisher Scientific, Hemel Hempstead, UK) were coated with ECM proteins following the relevant
manufacturer’s protocol.
Integrin blocking experiments
Antibodies previously reported to have blocking function against integrin subunits [25–32] were added at
a concentration of 1:200 in BEGM and the antibody–cell suspension was kept on ice for 20 min before
addition to ECM-coated or decellularised dermis scaffold containing wells for experiments examining cell
attachment. Untreated cells were used as controls. In cell expansion experiments, cells were allowed to
adhere for 2 h before they were washed with phosphate-buffered saline (PBS) and the medium replaced
with BEGM containing the blocking antibodies. For experiments examining differentiation, blocking
antibodies were refreshed with medium changes following air lift as indicated in figure legends. The
antibodies used to block integrin subunits were: α1 (5E8D9; NBP2-29757, Novus Biological, USA), α2
(P1E6-C5; 359304, Biolegend, San Diego, USA), α3 (ASC-1; MAB2056Z, Merck Millipore, Watford, UK),
αv (NKI-M9; 327904, Biolegend), α5 (NKI-SAM-1; 328004, Biolegend), α6 (GoH3; 313614, Biolegend),
α9β1 (Y9-A2; OBT1715Z, Bio-Rad, California, USA) and β1 (P5D2; MAB1959Z, Merck Millipore).
Attachment, proliferation and metabolic assays
For assays involving ECM-coated plates, non-adherent 96-well plates were coated with ECM as described
above and cells were seeded in BEGM before 30 min incubation at 37 °C, 5% carbon dioxide. Wells were
washed three times with PBS to remove unbound cells and plates were frozen at −80 °C. To quantify the
number of cells attached, plates were thawed to room temperature and a cell lysis buffer containing green
fluorescent DNA dye (CyQUANT GR, Life Technologies, Hemel Hempstead, UK) was added according to
the manufacturer’s protocol. Fluorescence was measured using a microplate reader (excitation 480 nm,
emission 520 nm) and background fluorescence was subtracted from these readings. To determine cell
expansion on ECM substrates, the above steps were performed at 2 h and 48 h post-cell seeding. Cell
number was calculated using a reference standard curve of known cell number.
To assess HBEC attachment to candidate scaffold materials, cells were seeded in non-adherent 96-well plates
containing the scaffolds. After 1 h, the wells were washed four times with PBS to remove unbound cells and
trypsin was applied to detach the adhered HBECs. Scaffolds were assessed by light microscopy to ensure
detachment of adhered cells, collected and plated into a separate 96-well plate. A DNA dye (CyQUANT GR,
Life Technologies) was used to compare cell attachment as described above. To assess the viability of
epithelial cells seeded on decellularised dermis or tracheal scaffolds, a cell viability assay (alamarBlue, Life
Technologies) was used. Cells were seeded onto decellularised scaffolds at the bottom of a 96-well plate and
incubated for 1 h. Scaffolds were then washed with PBS, transferred to a new well and alamarBlue cell
viability reagent was added in medium (1:10 ratio). After 2 h, fluorescence (excitation 560 nm, emission
590 nm) was recorded and a final value calculated by subtracting values generated from negative control
wells containing scaffolds but no epithelial cells.
Air–liquid interface culture and trans-epithelial electrical resistance
For standard air–liquid interface (ALI) cultures on positron emission tomography (PET) membranes,
HBECs (1×106) were seeded in 0.4 μM, 12 mm PET membrane transwells (Corning, Flintshire, UK) and
incubated at 37 °C with 5% carbon dioxide supply [33]. ALI conditions in which medium was removed from
the apical well were applied after 2 days. Cells were fed with ALI medium containing BEGM and DMEM at
a ratio of 1:1 supplemented with 100 μg·mL−1 streptomycin and 100 units·mL−1 penicillin, as well as freshly
prepared retinoic acid equivalent to 100 nM final concentration. Trans-epithelial electrical resistance (TEER)
was measured using an EVOM2 resistance meter and Endohm chamber (World Precision Instruments,
USA). Both the apical and basolateral sides of cultures were filled with BEBM (Lonza) and three replicate
readings were taken for each well, allowing values to stabilise for 5–10 s each time.
Production of candidate scaffolds
To produce decellularised dermis, glycerol-preserved cadaveric human skin was sourced from the Euro
Tissue Bank (Beverwijk, The Netherlands). Decellularisation was carried out by washing three times in
PBS over a 48-hour period and incubating the skin for 24 h at 37 °C in 1M sodium chloride as described
by DESHPANDE et al. [34]. The epidermis was then peeled off and the decellularised dermis was used either
directly or stored for up to 1 month at 4 °C in DMEM. POSS-PCU was provided by the Department of
Nanotechnology (University College London, UK), where it was produced using previously published
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methods [35]. Biomimetic collagen I scaffolds were prepared using custom-made absorbers following the
manufacturer’s protocol (RAFT™, Lonza). In brief, rat tail collagen I (First Link, Wolverhampton, UK),
DMEM and minimum essential medium (MEM) 10x (ThermoFisher Scientific, Hemel Hempstead, UK)
were combined in an 8:1:1 ratio, neutralised with 5M sodium hydroxide and incubated for 15 min to allow
the solution to gel. Absorbers were placed onto the surface of each well for 15 min to dehydrate the gel
and produce translucent collagen scaffolds [36].
Tracheae for decellularisation were obtained from terminated New Zealand White (NZW) rabbits (Envigo,
Huntingdon, UK). Tracheae were stripped of all fascia and washed three times in PBS containing
penicillin and streptomycin (1X, Gibco) over 24 h. Tracheae were then decellularised using a two-cycle
enzymatic detergent decellularisation protocol previously published by CONCONI et al. [37]. Briefly, tracheae
were placed in a 4% sodium deoxycholate solution (S1827, Sigma-Aldrich) for 4 h with luminal agitation
at room temperature, washed in PBS for 30 min with luminal agitation at room temperature, placed in a
solution of 1 L of 1M sodium chloride containing 22.5 mg deoxyribonuclease I (9003989, Sigma) for 3 h
and then washed in Milli-Q water overnight at 40 °C before repeating the above steps for the second cycle.
After completing the second cycle, the tracheae were washed in Milli-Q water for 3 days at 40 °C with the
water being changed daily. Finally, they were sterilised using ionising radiation.
Assembly of tissue-engineered respiratory mucosa
Decellularised dermis prepared using the method described above was clipped into CellCrowns™
(Sigma-Aldrich) fitting either 24-well plates for in vitro experiments or 12-well plates for in vivo
experiments. HBECs and lung fibroblasts were co-seeded onto the dermis at densities of 1×106 per cm2
and 1×104 per cm2, respectively, in 1 mL of epithelial cell culture medium. Scaffolds were maintained
submerged in epithelial cell culture medium containing 5 µM Y-27632 [23] and the medium was changed
daily. After 7 days, the CellCrowns™ were removed from the plates and those containing the scaffolds
were placed into 0.4 µm PET membrane transwell inserts (Corning) for ALI culture [38]. Medium was
changed to ALI medium, which was changed three times per week. Beyond 2 weeks at ALI, scaffolds were
cleared of mucus by gentle aspiration every other day. After 3–4 weeks at ALI, high-speed videos were
taken using an inverted microscope system (Nikon Ti-U 1000, Nikon, Japan) with a 40× objective and a
1.5× magnifier to assess ciliary beat frequency and pattern. The digital camera (Motion Pro 4x; IDT,
Pasadena, USA) was set for 512×512 regions of interest and recorded at 250 frames·s–1 for ciliary beat
frequency and 500 frames·s–1 for ciliary beat pattern. Ciliary beat frequency was analysed using CiliaFA
[39] and also calculated by determining the number of frames required for five full sweeps of the ciliary
tip. Ciliary dyskinesia was assessed by defining the uncoordinated ciliary beat pattern across a strip of
ciliated epithelium. The dyskinesia score was calculated from the percentage of dyskinetic ciliated cells
against the total number of ciliated cells.
Histology
Samples for histology were washed twice in PBS and fixed in 10% neutral buffered formalin (NBF) for 1 h.
Epithelialised scaffolds were fixed for 30 min and embedded in HistoGel (ThermoFisher Scientific) to
protect the top layer of epithelium from detachment during processing. After fixation, samples were stored
in 70% ethanol at 4 °C before dehydration using an automated system (Leica TP 1050, Leica, London,
UK). Formalin-fixed, paraffin-embedded samples were sectioned at 5 µm thickness. Haematoxylin and
eosin staining was performed using an automated Sakura DRS-601 staining machine (Sakura, Alphen aan
den Rijn, The Netherlands). Samples were mounted using a Sakura Coveraid (Sakura) automatic
cover-slipping machine with Tissue-Tek cover slip film (Bayer Diagnostics, Reading, UK).
Immunofluorescence
Slides were dewaxed for immunofluorescence using an automated process (DRS-601, Sakura) and then
washed in distilled water and blocked with PBS containing 10% FBS (block solution) for 2 h. Primary
antibodies were applied in block solution and incubated at 4 °C overnight. Following three PBS washes,
species-specific secondary antibodies (AlexaFluor, ThermoFisher Scientific) were applied in block solution
at a concentration of 1:200 for 1 h at room temperature. Slides were washed a further two times in PBS
and stained with 4′,6-diamidino-2-phenylindole (DAPI) (5 mg·mL−1 stock, 1:10000 in PBS; Life
Technologies) for 10 min. Following a final PBS washing step, slides were cover-slipped using ImmuMount
(GeneTex, Irvine, USA), sealed with nail varnish and imaged on a Zeiss 700 confocal microscope (Zeiss,
Oberkochen, Germany).
Immunocytochemistry
For top-down images, scaffolds were washed twice in PBS, fixed in 10% NBF for 30 min, washed twice in
PBS for 5 min each and incubated in block solution for 2 h at room temperature. Primary antibodies were
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applied in block solution and incubated overnight at 4 °C. After three 5-minute washes in PBS,
species-specific secondary antibodies were applied at 1:200 in block solution at room temperature for 1 h.
Scaffolds were washed twice in PBS and DAPI (5 mg·mL−1 stock, 1:10000 in PBS; Life Technologies) was
applied. Samples were washed in PBS before imaging, either in situ or following removal from wells and
cover-slipping using ImmuMount (GeneTex, Irvine, USA), using a Zeiss 700 confocal microscope (Zeiss).
To assess cell viability on the surface of scaffolds, a live/dead cell viability assay was used (ThermoFisher
Scientific). Calcein AM (3.4 µL·mL−1) and ethidium homodimer-1 (4 µL·mL−1) were mixed with medium
and added to scaffolds following cell adhesion. The scaffolds were incubated for 45 min and mounted on
glass slides for top-down, whole-mount imaging on a Zeiss 700 confocal microscope (Zeiss).
Scanning electron microscopy
Scaffolds were fixed in 2.5% glutaraldehyde, washed with 0.1 M phosphate buffer (pH 7.4) and distilled
water, dehydrated in a graded ethanol–water series to 100% ethanol and dried using carbon dioxide. Using
sticky carbon tabs, the scaffolds were then mounted on aluminium stubs and coated with a 2 nm layer of
gold/palladium using an ion beam coater (Gatan, California, USA). The scaffold surface was imaged using
a Jeol 7401 field emission scanning electron microscope (Jeol, Welwyn Garden City, UK). Ciliary length
measurements were made at 20000× screen magnification by electron microscopy.
Chick chorioallantoic membrane assay
Fertilised Bovan Brown chicken eggs were supplied by Henry Stewart & Co (Norfolk, UK). In brief, at
Embryonic Day 3, eggs were cleaned with 70% ethanol and 3–4 mL of albumin was removed via needle
aspiration at the apex of the shell. A 2×2 cm window was excised from the upper aspect of the shell to
reveal the embryo and chorioallantoic membrane (CAM) blood vessels. Windows were sealed with
adhesive tape and the eggs were incubated for a further 5 days. At Embryonic Day 8 the CAM was
re-exposed and minutia pins were used to disrupt several of the smaller blood vessels. Sections of test
scaffold (2 mm2) were placed gently onto the CAM with the epithelial side upwards and excess blood was
drained. The window was re-sealed and the eggs incubated until Embryonic Day 10. Following imaging
with a Leica Zoom 2000 stereomicroscope (Leica) with camera adaptor (Magnifi™, Arcturus Labs, Kansas,
USA), grafted CAMs were harvested and fixed overnight in 4% paraformaldehyde (PFA). A section of
sterile plastic casing was used as a negative control and acellular decellularised dermis was used to examine
the effect of including human cells. Comparison of epithelialised scaffolds was performed in two separate
experiments involving at least six eggs in each experimental group. Comparison of acellular dermis was
performed in one experiment with at least six eggs in each experimental group.
Engraftment of tissue-engineered respiratory mucosa on decellularised trachea in rabbits
Male NZW rabbits aged 9–10 weeks weighed 2.5–3 kg on arrival. General anaesthesia was induced using
0.5 mL·kg−1 ketamine intramuscularly and 0.2 mL·kg−1 of xylazine, and was maintained with sevoflurane
(all drugs supplied by National Veterinary Services, Stoke-on-Trent, UK). Sections of decellularised trachea
(5 cm) were pre-implanted in a lateral thoracic muscle flap raised from the chest and tunnelled under the
cervical skin into the neck in order to create a vascularised scaffold on which to graft engineered mucosa.
A Foley catheter (size 16F) was inserted through the lumen, cut to size and sutured in place at either end
with 4.0 Prolene sutures (Ethicon, Berkshire, UK) to act as a stent and prevent scaffold collapse. The
trachea was then wrapped in the muscle flap and secured within the neck using a 3.0 silk suture (Ethicon)
and the wound closed. Concurrently, HBECs and fibroblasts were seeded onto decellularised dermis to
fabricate the respiratory mucosal grafts as described above. After 4 weeks of pre-vascularisation, the
cervical incision was re-opened and the scaffold identified in the muscle wrap. The trachealis was
identified and opened by incision directly through muscle. The tracheal rings were visually assessed for
evidence of vascularisation, structural integrity and signs of infection, before the newly fabricated
tissue-engineered mucosa was grafted onto the luminal surface. A Foley catheter stent or Kaltostat
alginate-based dressing (Convatec, Flintshire, UK) was placed over the graft to protect the epithelial layer
and a stent placed to prevent displacement of the graft within the muscle flap. The tracheal and cervical
incisions were closed and the animals were terminated either 24 h or 1 week post-transplantation.
Immunosuppression of rabbits was required to reduce the probability of acute rejection of the transplanted
human cells [40]. Tacrolimus (Cambridge Bioscience, Cambridge, UK) was administered subcutaneously
at 0.3 mg·kg−1 for three consecutive days, beginning 7 days before the day of surgery and then on alternate
days until the end of the experiment. Dexamethasone was co-administered in later experiments at a dose
of 2 mg·kg−1 three times daily, beginning 24 h before grafting (supplementary table S2). Blood samples
were taken on the day of graft implantation and sent to the Royal Veterinary College (Hatfield, UK) for
quantification of white cells, lymphocytes and neutrophils.
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Engraftment of tissue-engineered respiratory mucosa in immunosuppressed mice
NOD SCID mice (Envigo) were anaesthetised and maintained with sevoflurane (National Veterinary
Services). A 5-cm transverse incision was made on the back of the mouse and a subcutaneous pocket
made. Decellularised dermis-based respiratory mucosal sheets were then laid onto the surface of the
muscle and a layer of Mepitel silicone dressing (Mölnlycke Healthcare, Gothenburg, Sweden) was laid over
the top to prevent shear. After 7 days, the mice were terminated, the wound was reopened and the graft
and underlying mouse muscle were explanted for histological processing.
Statistics
Statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego CA, USA) as
indicated in the figure legends. p-Values are reported rounded to three decimal places and statistical
significance was assigned for p<0.05. All in vitro experiments were carried out in at least technical
triplicates unless otherwise indicated and repeated as described in the figure legends. Data are presented as
mean±SEM values.
Results
Extracellular matrix dependent human airway epithelial cell attachment, proliferation and
differentiation
We first assessed the attachment of cultured primary human bronchial epithelial cells (HBECs) [41–43] to
ECM proteins found in the native human airway (supplementary figure S1), finding that collagen
IV-coated wells performed best with significantly more cells attaching than to laminin-coated or
vitronectin-coated wells (figure 1a). To determine the integrin mediators of this ECM attachment, we
performed attachment assays to ECM proteins in the presence of blocking antibodies against various
integrin α subunits. Blocking integrin α2 led to significantly lower levels of epithelial cell attachment to
collagen IV but blocking integrin subunits α3, αv, α5 and α6 had no effect (figure 1b). Other than a trend
towards decreased attachment to collagen I in the presence of an integrin α2-blocking antibody,
attachment to collagen I or fibronectin was variable between experimental replicates but unaffected by the
presence of these blocking antibodies (figure 1b). To determine the effect of ECM proteins on early
epithelial proliferation after attachment, HBECs were seeded onto wells coated with matrix proteins that
supported epithelial cell attachment and cell number was determined after 2 h and 48 h. No significant
change in HBEC number was seen when these proteins were combined with laminin to more closely
mimic the native ECM (figure 1c) but blocking antibodies against integrin β1 significantly curtailed early
HBEC expansion on collagen IV-coated wells and laminin-coated wells (figure 1d). No inhibition of
proliferation was seen in the presence of blocking antibodies against integrins α2, α3, α5, α6 or α9β1
(figure 1d).
To determine the effect of integrin blockade on HBEC differentiation, blocking antibodies against
integrins α1, α2, α3, α5, α6 or β1 were added to ALI cultures at the point of air exposure (and at medium
changes thereafter). Epithelial integrity increases during the establishment of a polarised, differentiated
epithelial layer through the formation of tight junctions. To examine this process, TEER was measured on
Days 0, 7, 14, 21 and 28 after air exposure. Epithelial integrity was disrupted by inhibition of integrin α1
and integrin α3, both of which are expressed in native human airway epithelium (supplementary figure
S2), indicating a failure of cells to differentiate appropriately. TEER values were unaffected in the presence
of blocking antibodies against integrins α2, α5, α6 or β1 (figure 1e) and epithelial differentiation to
towards multiciliated and mucosecretory cells was not obviously altered by these blocking antibodies, as
evidenced by high-speed video microscopy at Day 21 and immunofluorescence staining of independent
cultures incubated with blocking antibodies (supplementary figure S3). In wells treated with integrin α1-
and α3-blocking antibodies, no evidence of ciliation was detected and cell adherence to the PET
membrane had largely failed consistent with TEER readings (figure 1e).
Extracellular matrix proteins and attachment in tissue-engineered scaffolds
To move our experiments towards airway mucosal regeneration, we investigated attachment of epithelial
cells to three relevant scaffolds of varying ECM complexity (figure 2a): a complex biological scaffold that
retained multiple ECM proteins including collagen IV and laminin after decellularisation (decellularised
dermis) (figure 2b); a simpler collagen I matrix; and a synthetic POSS-PCU scaffold that did not contain
ECM proteins. Epithelial cell attachment to the complex decellularised scaffold was greater than to the
collagen I and POSS-PCU scaffolds (figure 2c), suggesting that the functionality of the ECM is retained
despite possible alterations in its structure caused by decellularisation. We further investigated how
decellularised dermis performed compared to decellularised trachea. After live/dead staining, abundant live
cells were seen on the surface of decellularised dermis scaffolds, whilst only sparse coverage was seen on
the decellularised tracheal scaffold (figure 2d). Correspondingly, in alamarBlue cell viability assays, there
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was a trend towards higher fluorescence intensity at 2 h following cell seeding onto decellularised dermis
scaffolds compared to decellularised tracheal scaffolds (figure 2e). This indicated better adherence and/or
cell survival on decellularised dermis, which was consistent with the two decellularisation protocols
preserving matrix to different extents (supplementary figure S4). Similar to experiments on collagen IV
(figure 1b), epithelial cell attachment to decellularised dermis was lower following blockade of integrin α2
(figure 2f).
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FIGURE 1 The role of extracellular matrix (ECM) proteins in human bronchial epithelial cell (HBEC) behaviour. a) HBECs (5×104) were seeded on
non-adherent tissue-culture plastic coated with ECM proteins and attachment was determined at 30 min using CYQUANT GR (ThermoFisher
Scientific, Hemel Hempstead, UK) with background fluorescence subtracted. Attachment to collagen IV was greater than to laminin (two-way
ANOVA with Holm-Sidak’s test for multiple comparisons) and vitronectin-coated wells. The experiment was repeated three times in technical
triplicate, including using two independent donor cell cultures. Data are presented on a log scale. b) HBECs were incubated in blocking antibodies
against integrins α2, α3, αv, α5 and α6 for 20 min before cells (2×104) were seeded onto non-adherent tissue-culture plastic wells coated with
either collagen IV, collagen I or fibronectin. Fluorescence with background subtracted was measured using CYQUANT GR. Blocking integrin α2 led
to significantly less HBEC attachment in the collagen IV-coated wells (one-way ANOVA with Holm-Sidak’s test for multiple comparisons), but not
the collagen I- (p=0.141) or fibronectin-coated wells (p=0.881), compared to control wells. The experiment was repeated three times in technical
triplicate (indicated in black, grey and white), including using two independent donor cell cultures. c) HBEC cell number was determined using
CYQUANT GR and a standard curve of known cell number at 2 h and 48 h after seeding HBECs (1×104) onto non-adherent tissue-culture plastic
coated with ECM proteins. No statistical difference was found between the groups (one-way ANOVA with Holm-Sidak’s test for multiple
comparisons; p>0.25 for all comparisons). The experiment was repeated three times in technical triplicate, including using two independent donor
cell cultures. d) Blocking antibodies were added to wells 2 h after seeding HBECs (5×103) onto collagen IV- and laminin-coated wells.
Fluorescence with background subtracted was recorded at 48 h using CYQUANT GR and compared to a control well without blocking antibody.
Significantly less epithelial cell proliferation was observed compared to the control in the presence of integrin β1-blocking antibody (one-way
ANOVA with Holm-Sidak’s test for multiple comparisons). The experiment was repeated six times in technical triplicate, including using two
independent donor cell cultures. e) Integrin blocking antibodies were added to air–liquid interface (ALI) cultures at the point of ALI creation and at
every feed thereafter. Trans-epithelial resistance (TEER) as a measure of epithelial integrity was recorded at five timepoints after air-lift
(1=0 days, 2=7 days, 3=14 days, 4=21 days and 5=28 days). Blockade of α1 and α3 integrins inhibited trans-epithelial resistance (two-way ANOVA
with Holm-Sidak’s test for multiple comparisons). The experiment was performed by making three repeated measurements from duplicate wells
from two independent donor cell cultures (i.e. four independent wells at each timepoint). Data are presented on a log scale. *: p=0.018; **:
p=0.002; ***: p=0.006; ****: p<0.001.
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Culture of tissue-engineered respiratory mucosa
Based on these findings, we investigated the use of decellularised dermis as a substrate for respiratory
mucosal regeneration. HBECs and primary human lung fibroblasts [44, 45] were cultured on decellularised
dermis at an ALI for 3 weeks in order to induce differentiation of basal cells to mature epithelium containing
mucosecretory and ciliated cells [38], as is seen in the native human airway (figure 3a). Consistent with
previous observations using this scaffold material [46], mucus was observed on the surface of the scaffold
after 2 weeks and by 3 weeks ciliary beat could be observed by top-down, high-speed digital video
(supplementary material). Haemotoxylin and eosin staining of sections taken 3 weeks post-ALI demonstrated
an intact epithelial layer across the extent of the scaffold, with both ciliated cells and mucus-containing
secretory cells (figure 3b). The fate of fibroblasts remained uncertain however, as although fibroblasts had
not convincingly repopulated the lamina propria (figure 3b), very rare cells with a fibroblastic morphology
were observed by immunofluorescence (supplementary figure S5). The height of the pseudostratified layer
was variable along the length of the scaffold but immunofluorescence staining demonstrated the expression
of keratin, mucin 5AC (MUC5AC), indicating the presence of mucosecretory cells, acetylated tubulin (ACT)
in cilia and the basement membrane ECM proteins collagen IV and laminin (figure 3c). Expression of
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FIGURE 2 Attachment of human bronchial epithelial cells (HBECs) to tissue-engineered scaffolds. a) Digital photographs of the three scaffolds
tested: decellularised dermis (biological), POSS-PCU (synthetic) and dehydrated collagen I (biomimetic). b) Whole-mount, top-down
immunofluorescence staining of the basement membrane proteins collagen IV and pan-laminin in decellularised dermis indicates that these
matrix proteins are preserved following decellularisation. c) HBECs (5×104) were seeded into each scaffold-containing well. After 1 h, the wells
were washed and trypsin was applied to detach the HBECs that had adhered to the scaffolds. In a separate 96-well plate, CYQUANT GR
(ThermoFisher Scientific, Hemel Hempstead, UK) was used to measure fluorescence of attached cells with values from unseeded control
scaffolds subtracted. Fluorescence was significantly greater in the decellularised dermis group compared with the collagen I (one-way ANOVA
with Holm-Sidak’s test for multiple comparisons) and POSS-PCU scaffolds. The experiment was repeated three times in technical triplicate,
including using two independent donor cell cultures. d) Whole-mount, top-down confocal images showing live/dead staining of decellularised
dermis and tracheal scaffolds at 2 h post-epithelial cell seeding. e) Cell viability of epithelial cells (1.5×105) seeded on decellularised dermis or
trachea was compared using an alamarBlue (ThermoFisher Scientific) cell viability assay. Fluorescence intensity was measured at 2 h following
adherence and values from negative control scaffolds were subtracted. Fluorescence intensity was greater in the dermis group compared to the
tracheal group but the finding did not reach statistical significance (two-tailed, paired t-test). The experiment was repeated three times in
technical triplicate, including using two independent donor cell cultures. f ) HBECs (1.5×105) were seeded onto decellularised dermis scaffolds
with and without pre-treatment with an integrin α2-blocking antibody. Cells were washed at 1 h and an alamarBlue cell viability assay was
performed with background fluorescence subtracted. Blocking integrin α2 resulted in significantly less attachment of cells to decellularised
dermis (paired t-test). The experiment was performed four times in technical triplicate, including using two independent donor cell cultures. All
scale bars=50 µm. *: p=0.029; **: p=0.015; ***: p=0.006.
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FIGURE 3 Human bronchial epithelial cell (HBEC) differentiation on decellularised dermis scaffolds at the air–
liquid interface (ALI). a) Haematoxylin and eosin stained section of adult human tracheal mucosa. A
pseudostratified layer of ciliated epithelium with mucus-secreting goblet cells can be seen overlying the
basement membrane. The lamina propria lies underneath the basement membrane. b) Haematoxylin and
eosin stained section of the respiratory mucosa cultured on decellularised dermis. A differentiated epithelial
layer is seen along the length of the scaffold and cells with the morphological appearance of
mucus-secreting goblet cells and ciliated cells are seen. c) Immunofluorescence staining of sections of
bioengineered respiratory mucosa. The 4′,6-diamidino-2-phenylindole (DAPI)-positive cell layer stained
positively for the epithelial marker pan-keratin (green), the mucosecretory cell associated mucin 5AC
(MUC5AC) (red), the ciliary protein acetylated tubulin (ACT) (red), the basement membrane proteins collagen
IV (yellow), pan-laminin (blue) and integrin α2 (red). d) Top-down confocal microscopy for markers of
differentiation on decellularised dermis-based respiratory mucosa demonstrated ACT (red) and MUC5AC
(yellow) positivity. e) Electron microscopy of decellularised dermis-based respiratory mucosa. Cilia can be
seen on the surface of the scaffold. f ) High-speed digital video analysis of one donor HBEC culture
differentiated on either standard positron emission tomography (PET) ALI substrates (controls; n=5 videos) or
decellularised dermis scaffolds (n=10 videos). Analysis of ciliary beat frequency and dyskinesia demonstrated
that on decellularised dermis cilia exhibited a comparable beat frequency to the control substrate. The
dyskinesia score was slightly higher than in controls but remained within normal range. Scale bars=50 µm in
(a)–(d) and 10 µm in (e).
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integrin α2, identified earlier as an important mediator of epithelial attachment (figure 1b) was also seen
throughout the differentiated epithelium (figure 3c). Top-down immunofluorescence confirmed the presence
of ACT-positive ciliated cells and MUC5AC-positive mucosecretory cells across the surface of the scaffold
(figure 3d). Electron microscopy of the mucosal sheets further confirmed the presence of ciliated cells on the
apical surface of the dermis-based scaffold (figure 3e). Ciliary length measurements were made on between
seven and 10 cilia per cell from six different ciliated cells from five separate strips of epithelium. Cilia from
three of the cells were of normal length (length±standard deviation (SD): 5.5±0.3 µm, 5.6±0.3 µm, 5.7
±0.4 µm) and cilia from three cells were slightly shorter (5.4±0.3 µm, 5.0±0.2 µm, 5.0±0.3 µm) suggesting
ciliogenesis might be on-going or incomplete in some cells. Importantly, analysis of ciliary beat frequency
showed that it was comparable to that seen using a standard PET ALI culture substrate (figure 3f). Finally,
the ciliary dyskinesia score of cells on decellularised dermis scaffolds was within the anticipated range for
ciliated ALI cultures (figure 3f).
Grafting of tissue-engineered respiratory mucosa onto chick chorioallantoic membrane
Having determined that the decellularised dermis matrix was capable of supporting a differentiated
respiratory epithelium in vitro, we next assessed short-term engraftment of decellularised dermis scaffolds
seeded with HBECs and lung fibroblasts onto a vascularised surface in a chick CAM assay (figure 4a). The
CAM assay has the advantages of immune naivety, rapid neo-vascularisation and exposure of engrafted
tissue to an air interface. At 48 h post-graft, top-down digital photography showed small blood vessels
penetrating the scaffold, indicating neo-vascularisation (figure 4b), in contrast to plastic negative controls
that showed no such vascularisation (figure 4b). Sections of acellular decellularised dermis also demonstrated
neo-vascularisation (figure 4b), indicating that this process was not dependent on the inclusion of
transplanted cells. Haematoxylin and eosin stained sections of the engineered respiratory mucosa at this
time-point demonstrated preservation of the epithelium (figure 4c). Furthermore, immunofluorescence
staining confirmed their human (STEM121) (figure 4d) and epithelial (pan-keratin) (figure 4d) origin and
showed rare cells expressing the mucosecretory cell-associated protein MUC5AC (figure 4d). However, an
absence of ACT+ cilia suggested that epithelial remodelling had occurred in the in vivo environment.
Grafting of tissue-engineered respiratory mucosa in vivo
Finally, we investigated whether we could apply these decellularised dermis-based respiratory mucosal
sheets to a pre-vascularised, decellularised trachea in an in vivo rabbit model [47] (figure 5 and
supplementary table S2). If successful mucosal regeneration were achieved in this manner, the construct
could be rotated on its vascular pedicle to replace a section of damaged trachea and provide a
re-mucosalised and vascularised section of airway at the point of transplantation. Segments of
decellularised rabbit trachea 5-cm in length were implanted into muscle flaps in the necks of NZW
rabbits. We allowed 4 weeks for scaffold vascularisation and initiated immunosuppression before surgical
grafting. To monitor immunosuppression, venous blood was sampled on the day of mucosal grafting. In
our initial experiment, immunosuppression consisted of tacrolimus only and lymphocyte counts were
within normal range (figure 5b). After 7 days, grafts on tracheae had integrated macroscopically (figure 6a)
but did not show a preserved epithelial layer (two out of two) (figure 6b). An intense inflammatory
reaction was observed and subsequently the immunosuppressive regime was modified to include
dexamethasone. The combination of dexamethasone and tacrolimus caused lymphopenia (figure 5c) and
led to a less intense inflammatory reaction within the implanted dermis layer at 7 days (figure 6c). Very
sparse areas of keratin-positive epithelial cells could be found in these rabbits (two out of three) (figure
6c). To counteract the possibility of mechanical shear damaging the engrafted epithelial layer, we finally
implanted decellularised dermis-based airway mucosal sheets with a protective layer of soft alginate
dressing in place of a silicone stent. At 24 h after engraftment, the epithelial layer was preserved in one out
of two rabbits (figure 6d) and demonstrated appropriate expression of markers associated with
mucosecretory and ciliated differentiation (figure 6d). However, vascular channels did not appear to
penetrate to the surface and the mucosal layer was detached from the underlying stromal layer following
processing and sectioning, possibly indicating weak integration (figure 6d). After 5 days, the bioengineered
graft was well-integrated with some evidence of re-vascularisation (figure 6e) but the epithelial layer had
been lost (two out of two) (figure 6e). Blood cells and diffuse inflammatory cell infiltration were observed
within the decellularised dermis at this time point (figure 6e).
Due to the possibility of incomplete immunosuppression leading to these results in rabbits, we further
investigated in vivo integration in NOD SCID mice. Decellularised dermis-based airway mucosal sheets were
grafted onto back muscle and overlaid with a silicone dressing to protect the epithelial layer (figure 7a).
After 7 days, the grafts were retrieved and histology demonstrated retention of epithelial cells (three out of
three) (figure 7b), although coverage of scaffolds varied among replicates. Retained epithelial cells expressed
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the basal cell-associated protein keratin 5 (figure 7c), suggesting that remodelling had occurred, perhaps
because of the lack of polarity signals available to the epithelial cells in this experimental model.
Discussion
Collagen IV and laminin anchor multiple epithelia, including airway, skin [21], small intestine [48] and
cornea [49], to the underlying stroma in vivo [50]. Supporting their active role in epithelial remodelling,
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FIGURE 4 Engraftment of decellularised dermis-based airway mucosal grafts in the chick chorioallantoic
membrane assay (CAM). a) Timeline of the chick CAM assay. The egg is incubated and then windowed at
Embryonic Day 3, while the scaffold is grafted at Embryonic Day 8 before harvest at Embryonic Day 10. b) Digital
photographs of CAM assays after 2 days. c) Haematoxylin and eosin stained sections of the respiratory mucosal
layer grafted onto CAM assay at Embryonic Day 10. An epithelial layer is demonstrated on the surface of the
dermis overlying the CAM. Higher magnification of the epithelial layer demonstrates preservation of an epithelium
but apparent loss of cilia. d) Immunofluorescence staining of sections of decellularised dermis-based respiratory
mucosa. The 4′,6-diamidino-2-phenylindole (DAPI)-positive cell layer stained positively for the epithelial marker
pan-keratin (green), the human cell marker STEM121 (yellow) and rarely the mucosecretory cell marker mucin
5AC (MUC5AC) (red). The CAM experiment involving epithelialised scaffolds was performed twice including six
eggs in each experimental group on each occasion. The decellularised dermis CAM experiment was performed
once with six eggs in each experimental group. All scale bars=50 µm. TE: tissue-engineered.
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collagen IV expression is reduced in partial thickness dermal wounds as epithelial cells migrate [51] and
laminin guides respiratory [52], epidermal [53] and corneal [49] epithelial cell migration. Our study
suggests that collagen IV is a key mediator of airway epithelial cell attachment and proliferation on
bioengineered scaffolds and that integrins α2 and β1 are mediators of these processes, consistent with the
known role of integrin α2/β1 as a receptor for both ECM proteins [54].
We believe that the presence (and native presentation) of collagen IV and laminin in bioengineered airway
constructs and/or manipulation of integrin α2 mediated adhesion, may improve epithelial cell attachment
efficiency and permit lower cell seeding densities to achieve scaffold coverage [22]. The benefits of this are
manifold as overall cell culture time, the number of population doublings experienced by cells in culture
and manufacturing costs could be reduced. Although this could take many forms, we identified
decellularised dermis as a promising scaffold material for airway regeneration based on its retention of
collagen IV and laminin. Compared to collagen I-based scaffolds, synthetic scaffolds and decellularised
tracheal scaffolds, primary HBECs adhered well to decellularised dermis in vitro. It is likely that the more
extensive decellularisation process required for whole trachea disrupts the collagen IV-rich basement
membrane, thus limiting epithelial adherence. Further research might aim to deploy decellularisation
methods that preserve key matrix proteins on the luminal surface or to develop methods to replace these
when they are lost through decellularisation.
Consistent with a previous report [46], we generated bioengineered respiratory mucosa with beating cilia
and mucus secretion by culturing primary HBECs on decellularised dermis at an ALI in vitro. We found
that the length of cilia was comparable to those in native airways and ciliary beat frequency and dyskinesia
scores were comparable to healthy human nasal cilia as assessed by high-speed video microscopy either
directly [55] or after culture at ALI [22]. Such scaffolds may be manipulated surgically and could be a
means to restore mucociliary coverage in respiratory mucosa that has been lost or damaged. To this end,
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FIGURE 5 Timeline for engrafting decellularised dermis-based airway mucosal grafts onto a pre-vascularised segment of decellularised trachea in
rabbits. a) Cadaveric rabbit trachea was decellularised using a series of enzymatic and detergent washes. Decellularised tracheae were
pre-implanted in the lateral thoracic muscle of New Zealand White (NZW) rabbits to promote vascularisation. At this time, human bronchial
epithelial cells (HBECs) and lung fibroblasts were seeded onto decellularised dermis and cultured at an air–liquid interface (ALI). After 4 weeks, the
muscle and tracheal composite was opened and the trachea visually assessed for signs of vascularisation, infection and for structural integrity ahead
of grafting the cultured respiratory mucosal graft onto the luminal surface. In some rabbits, alginate dressing was placed over the mucosal scaffold
to protect the epithelial cells and then stents were placed within the lumen to secure the graft in place. Immunosuppression began prior to
transplantation of bioengineered mucosal grafts. b) Immunosuppression efficacy with tacrolimus in rabbits (n=3; 0.3 mg·kg−1 subcutaneously for
3 days and then on alternate days; blood sampled on Day 7). Green bars indicate normal range. c) Immunosuppression efficacy with combined
tacrolimus and dexamethasone in the rabbit model (n=3; 0.3 mg·kg−1 tacrolimus subcutaneously for 3 days and then on alternate days; three doses
of 2 mg·kg−1 dexamethasone intramuscularly 24 h prior to blood sampling on Day 7). Green bars indicate normal range.
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we examined the performance of the scaffolds in CAM assays, finding that the epithelium was retained
2 days post-engraftment but that cilia were no longer present. The fate of these cells is unknown but our
data suggest that the CAM assay might act as an accessible short-term epithelial remodelling assay in the
window before 15 days when immune reactions to implanted material become limiting [56].
In a second in vivo study, we used a two-stage transplantation procedure in rabbits to test a decellularised
dermis-based bioengineered respiratory mucosal graft. The combination of tacrolimus and dexamethasone
resulted in a lymphopenia with preserved neutrophil count that could limit immune-mediated remodelling
of the scaffold whilst preventing immunosuppression-associated opportunistic infections. We saw
engraftment with short-term epithelial retention but were unable to demonstrate longer-term retention of
the differentiated epithelial layer. Delayed revascularisation may explain this observation, as penetration of
new vascular channels approximately 1 mm into the dermis scaffold is likely to take several days, during
which time the epithelium relies on diffusion of nutrients from the underlying graft bed [57]. Our team’s
experience in producing 3-D tissue-engineered skin and oral mucosa, including clinical engraftment,
shows that grafts placed on poorly vascularised beds often fail to survive [58]. The inclusion of endothelial
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FIGURE 6 Engraftment of decellularised dermis-based airway mucosal grafts onto pre-vascularised
decellularised tracheae in rabbits. a) Digital photograph of an explanted trachea 7 days after grafting with
bioengineered airway mucosa. The grafted scaffold can be seen on the luminal surface as a distinct layer
overlying the cartilage rings. b) Haematoxylin and eosin staining of explanted rabbit trachea 7 days after
grafting tissue-engineered respiratory mucosa (TERM) around a silicone stent with the use of tacrolimus
immunosuppression. The grafted TERM can be seen on the luminal surface with an intense inflammatory
infiltrate and loss of all epithelium (magnified section). Scale bars=1 mm (left) and 250 µm (right). c) Rabbit
trachea 7 days after grafting TERM around a silicone stent with the use of tacrolimus and dexamethasone
immunosuppression. The grafted TERM can be seen on the luminal surface with less inflammatory infiltrate
and some overlying epithelium that was incomplete over large portions (magnified area). Scale bars=1 mm
(left) and 100 µm (upper right). Sections were stained for keratin 5 (green) and 4′,6-diamidino-2-phenylindole
(DAPI) (blue). Keratin 5+ cells were found over small areas of the trachea (green). Scale bar=50 µm (lower
right). d) Haematoxylin and eosin staining of an explanted rabbit trachea 24 h after grafting with an alginate
dressing and dual immunosuppression. An epithelial layer was observed on the surface of one of the grafts
but the grafts had detached from the underlying trachea, perhaps during processing. Immunofluorescence
staining for the human cell marker STEM121 (yellow), mucin 5AC (MUC5AC) (yellow) and the ciliary protein
acetylated tubulin (ACT) (red) is shown. Scale bars=50 µm. e) Haematoxylin and eosin staining of explanted
trachea 5 days after grafting with an alginate dressing and dual immunosuppression. The epithelial layer had
been lost from the decellularised dermis. The magnified image shows evidence of blood cells within the
dermis layer and the presence of inflammatory cells. Scale bars=50 µm.
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cells and angiogenic growth factors has been shown to shorten the time for neo-vascularisation in
synthetic and biological scaffolds and may be a potential strategy to more rapidly restore a blood supply to
the epithelial layer [59, 60]. An alternative strategy would be to differentiate respiratory epithelial cells on a
thinner scaffold that enables the delivery of nutrients and oxygen to the epithelial layer from the
underlying capillaries by diffusion. Diffusion is limited to a distance of approximately 150 µm from the
capillary and therefore the scaffold would need to be of similar thickness [61–63]. Whether taking a
150 µm shave of dermis to include the collagen- and laminin-rich basement membrane and the underlying
lamina propria would shorten the time taken for revascularisation and enhance epithelial survival is a clear
target for future investigations.
The frequent loss of the epithelial layer in our in vivo experiments highlights the technical challenges of
grafting a new mucosal layer into the airway. In order to prevent displacement of a mucosal graft, a stent
is deployed that retains the graft on the graft bed whilst maintaining airway patency. However, the
dynamic properties of the airway inevitably result in mechanical shear of the stent against the engrafted
epithelial layer that is likely to result in further epithelial loss [64]. Future developments might adopt
custom-made stents with a supportive soft outer layer containing a nutrient supply that could enable
engraftment and maintain airway patency while simultaneously supporting and protecting the epithelium.
Alternatively, developing pro-angiogenic adhesives might allow grafting of the tissue-engineered respiratory
mucosa onto the trachea without the need for a stent.
Conclusions
Tissue-engineered whole organ transplants in the airways, but also in the bladder and bowel, are currently
limited by the inability to regenerate a functioning mucosal lining. Our findings indicated that the ECM
proteins collagen IV and laminin are important for respiratory epithelial adherence and expansion in vitro,
and informed the development of bioengineered scaffolds that contain a differentiated respiratory mucosal
layer on a decellularised dermis scaffold. The delivery of these scaffolds is feasible in vivo but, while
epithelium was retained in the short-term, further research is required to improve long-term in vivo
survival. Our work emphasises the importance of cell delivery methods in airway cell therapy research and
suggests the merit of pre-clinical studies that directly compare differentiated cell transplantation to basal
cell-only methods (although the success of the former would restore tissue function rapidly,
undifferentiated basal stem cells might be more robust for transplantation).
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Immunofluorescence staining confirmed that the monolayer was keratin 5-expressing (green). Slides were
counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue). All scale bars=50 µm.
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